Senior insider sale
Chief Financial Officer at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$130.7K
34.81K shares
What this filing means
TAYLOR BEN R plans to sell 34.81K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $130.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2026ACC: 0001959173-26-001109
Officer· Chief Financial Officer
Since Feb 2026
34.81K
Shares to sell
$130.7K
Approx. market value
13.43K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/15/2026
13.43KTotal acquired13.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/15/2026 | Restricted Stock Vesting Compensation | 13.43K | — |
| Total | 13.43K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
21.38K
Market value
$89.4K
12/29/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
13.43K
Market value
$41.4K
2/18/2026
Total
Units
34.81K
Value
$130.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/29/2025 | 21.38K | $89.4K | — | Completed |
| Planned — Approximate Date | ||||
2/18/2026 | 13.43K | $41.4K | NASDAQ | Planned |
| Total | 34.81K | $130.7K | ||